HeraMED Ltd 1I4
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.02
- Day Range
- €0.03–0.03
- 52-Week Range
- €0.00–0.10
- Bid/Ask
- €0.02 / €0.03
- Shares Outstanding
- 1.16B
- Market Cap
- A$31.86M
- Volume/Avg
- 10,000 / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 372.87
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.hera-med.com
Valuation
|
Metric
|
1I4
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 20.91 |
Price/Sales | 372.87 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
1I4
|
|---|---|
Quick Ratio | 8.92 |
Current Ratio | 9.09 |
Interest Coverage | −6,503.34 |
Quick Ratio
1I4
Profitability
|
Metric
|
1I4
|
|---|---|
Return on Assets (Normalized) | −138.80% |
Return on Equity (Normalized) | −212.52% |
Return on Invested Capital (Normalized) | −192.24% |
Return on Assets
1I4
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|dyD@^! | LOCK|N<Q& | $176B | |||
| Medtronic PLC
MDT
| LOCK|>TM<r!! | LOCK|!rCCq | $118B | |||
| Stryker Corp
SYK
| LOCK|&$!<G#M | LOCK|x<S | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|kcCqCL | LOCK|@M^ms | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|dQMfSms! | LOCK|^<Fk | $50B | |||
| DexCom Inc
DXCM
| LOCK|G#p!WkNQ | LOCK|f?Xy | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|J$R^tJ | LOCK|mX< | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Jy^ | LOCK|F>M | $24B | |||
| Steris PLC
STE
| LOCK|GX#wJss | LOCK|pRQgV | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|^h@!!<Gz | LOCK|&FB | $18B |
United States